DNA repair gene promoter methylation in non-small cell lung cancer (NSCLC) patients treated with DNA damaging agents.

被引：0
|
作者：
Buckingham, Lela [1 ]
Pelkey, Gregory [1 ]
Fidler, Mary J. [1 ]
Bonomi, Philip D. [1 ]
机构：
[1] Rush Univ Med Ctr, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22130
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EFFECT OF GERMLINE POLYMORPHISMS OF DNA REPAIR GENES ON CHEMOTHERAPY OUTCOME IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Sullivan, I. G.
    Majem Tarruella, M.
    Paez, D.
    Pallares, C.
    Pare, L.
    Del Rio, E.
    Lopez Pousa, A.
    Barnadas, A.
    Ramon Y Cajal, T.
    Baiget, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 408 - 408
  • [22] Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer
    Lee, Su Man
    Park, Jae Yong
    Kim, Dong Sun
    MOLECULES AND CELLS, 2012, 34 (02) : 171 - 176
  • [23] Molecular Evidence of Viral DNA in Non-Small Cell Lung Cancer (NSCLC) and Normal Lung
    Robinson, Lary A.
    Jaing, Crystal J.
    Giuliano, Anna R.
    Campbell, Christine M. Pierce
    Yoder, Sean J.
    Teer, Jamie K.
    Antonia, Scott J.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S714 - S714
  • [24] Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
    Ji, Meiju
    Zhang, Yong
    Shi, Bingyin
    Hou, Peng
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [25] Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
    Meiju Ji
    Yong Zhang
    Bingyin Shi
    Peng Hou
    Diagnostic Pathology, 6
  • [26] Plasma DNA Methylation Analysis in Predicting Short-Term Recurrence of Surgical Patients with Non-small Cell Lung Cancer (NSCLC)
    Ding, Qingqing
    Mu, Yuan
    Pan, Shiyang
    Shu, Yongqian
    Zhang, Shijiang
    Zhang, Bingfeng
    Wang, Hong
    Gao, Li
    Xia, Wenying
    Xu, Jian
    Zhang, Meijuan
    Zhang, Yuanyuan
    Cao, Yan
    Lu, Shan
    CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM, 2011, : 47 - 55
  • [27] Mitotic checkpoint gene CHFR methylation in pretreatment serum DNA of docetaxel (doc)/cisplatin (cis)-treated stage IV non-small cell lung cancer (NSCLC) patients (pts)
    Moran, T.
    Salazar, F.
    Cobo, M.
    Isla, D.
    Massuti, B.
    Montes, A.
    Provencio, M.
    Vinolas, N.
    Paz-Ares, L.
    Rosell, R.
    LUNG CANCER, 2006, 52 : S26 - S26
  • [28] Mitotic checkpoint gene CHFR methylation in pretreatment serum DNA of docetaxel (doc)/cisplatin (cis)-treated stage IV non-small cell lung cancer (NSCLC) patients (p).
    Isla, D.
    Salazar, F.
    Ramirez, J.
    Ronco, M. Sanchez
    Cobo, M.
    Montes, A.
    Sanchez, J.
    Catot, S.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 378S - 378S
  • [29] Prognosis of the surgical treatment of patients with non-small cell lung cancer (NSCLC) - relation to DNA ploidy
    Gawrychowski, J
    Lackowska, B
    Gabriel, A
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (06) : 870 - 877
  • [30] Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
    Zienolddiny, S
    Campa, D
    Lind, H
    Ryberg, D
    Skaug, V
    Stangeland, L
    Phillips, DH
    Canzian, F
    Haugen, A
    CARCINOGENESIS, 2006, 27 (03) : 560 - 567
12345